SEARCH

SEARCH BY CITATION

References

  • 1
    Marshall GS, Edwards KM, Butler J, Lawton AR. Syndrome of periodic fever, pharyngitis, and aphthous stomatitis. J Pediatr 1987;110:4346.
  • 2
    Feder HM Jr, Bialecki CA. Periodic fever associated with aphthous stomatitis, pharyngitis and cervical adenitis. Pediatr Infect Dis J 1989;8:186187.
  • 3
    Miller LC, Sisson BA, Tucker LB, Schaller JG. Prolonged fevers of unknown origin in children: patterns of presentation and outcome. J Pediatr 1996;12:419423.
  • 4
    Padeh S, Brezniak N, Zemer D, Pras E, Livneh A, Langevitz P et al. Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome. J Pediatr 1999;135:98101.
  • 5
    Thomas KT, Feder HM, Lawton AR, Edwards KM. Periodic fever syndrome in children. J Pediatr 1999; 135:1521.
  • 6
    Tasher D, Somekh E, Dalal I. PFAPA syndrome – new clinical aspects revealed. Arch Dis Child 2006;91: 981984.
  • 7
    Dahn KA, Glode MP, Chan KH. Periodic fever and pharyngitis in young children: a new disease for the otolaryngologist? Arch Otolaryngol Head Neck Surg 2000;126:11461149.
  • 8
    Galanakis E, Papadakis CE, Giannoussi E, Karatzanis AD, Bitsori M, Helidonis ES. PFAPA syndrome in children evaluated for tonsillectomy. Arch Dis Child 2002;86:434 435.
  • 9
    Berlucci M, Meini A, Plebani A, Bonvini MG, Lombardi D, Nicolai P. Update on treatment of Marshall’s syndrome (PFAPA syndrome): report of five cases with review of the literature. Ann Otol Rhinol Laryngol 2003;112:365369.
  • 10
    Abramson JS, Givner LB, Thompson JN. Possible role of tonsillectomy and adenoidectomy in children with recurrent fever and tonsillopharyngitis. Pediatr Infect Dis J 1989;8:119 120.
  • 11
    Ciambra R, Milocco C, Facchini S, Leone V, Locatelli C, Pocecco M. Periodic fever, aphthous stomatitis, pharyngitis and lymphadenopathy: a pediatric caseload. Pediatr Med Chir 2003;25:181184.
  • 12
    Pillet P, Ansoborlo S, Carrere A, Perel Y, Guillard JM. (P)FAPA syndrome: interet de la cimetidine. Arch Pediatr 2000;7:5457.
  • 13
    Feder HM. Cimetidine treatment for periodic fever associated with aphthous stomatitis, pharyngitis and cervical adenitis. Pediatr Infect Dis J 1992;11:318321.
  • 14
    Frye RE. Recurrent aseptic encephalitis in periodic Fever, aphthous stomatitis, pharyngitis and adenopathy (PFAPA) syndrome. Pediatr Infect Dis J 2006;25:463465.
  • 15
    Scimeca PG, James-Herry AG, Weinblatt ME. Atypical PFAPA syndrome (periodic fever, aphthous stomatitis, pharyngitis, adenitis) in a young girl with Fanconi anemia. J Pediatr Hematol Oncol 1996;18: 159161.
  • 16
    Parikh SR, Reiter ER, Kenna MA, Roberson D. Utility of tonsillectomy in 2 patients with the syndrome of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis. Arch Otolaryngol Head Neck Surg 2003;129:670673.
  • 17
    Lee WI, Yang MH, Lee KF, Lee KF, Chen LC, Lin SJ et al. PFAPA syndrome (periodic fever, aphthous stomatitis, pharyngitis, adenitis). Clin Rheumatol 1999;18:207213.
  • 18
    Rubin LG, Kamani N. Syndrome of periodic fever and pharyngitis (letter). J Pediatr 1987;111:307.
  • 19
    Stojanov S, Hoffmann F, Kery A, Renner ED, Hartl D, Lohse P et al. Cytokine profile in PFAPA syndrome suggests continuous inflammation and reduced anti-inflammatory response. Eur Cytokine Netw 2006;17:9097.
  • 20
    Cazeneuve C, Genevieve D, Amselem S, Hentgen V, Hau I, Reinert P. MEFV gene analysis in PFAPA. J Pediatr 2003;143:140141.
  • 21
    Drenth JPH, Cuisset L, Grateau G, Vasseur C, Van De Velde-Visser SD, De Jong JGN et al. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. Nat Genet 1999;22:178181.
  • 22
    Drenth JPH, Haagsma CJ, Van der Meer JWM, The International Hyper-IgD Study Group. Hyperimmunoglobulinemia D and periodic fever syndrome; the clinical spectrum in a series of 50 patients. Medicine (Baltimore) 2004;73:133144.
  • 23
    Haraldsson A, Weemaes CM, De Boer AW, Bakkeren JA, Stoelinga GB. Immunological studies in the hyper-immunoglobulin D syndrome. J Clin Immunol 1992;12:424428.
  • 24
    Klasen IS, Goertz JH, Van De Wiel GA, Weemaes CM, Van Der Meer JW, Drenth JP. Hyper-immunoglobulin A in the hyperimmunoglobulinemia D syndrome. Clin Diagn Lab Immunol 2001;8:5861.
  • 25
    Simon A, Kremer HPH, Wevers RA, Scheffer H, De Jong JG, Van Der Meer JWM et al. Mevalonate kinase deficiency; evidence for a phenotypic continuum. Neurology 2004;62:994997.
  • 26
    Houten SM, Woerden CSvW, Wijburg FA, Wanders RJA, Waterham HR. Carrier frequency of the V377I (1129G4A) MVK mutation, associated with Hyper-IgD and periodic fever syndrome, in the Netherlands. Eur J Hum Genet 2002;11:196200.
  • 27
    Simon A, Cuisset L, Vincent MF, Van Der Velde-Visser SD, Delpech M, Van der Meer JWM et al. Molecular analysis of the mevalonate kinase gene in a cohort of patients with the hyper-IgD and periodic fever syndrome: its application as a diagnostic tool. Ann Intern Med 2001;135:338343.
  • 28
    Simon A, Drewe E, Van Der Meer JWM, Powell RF, Kelley RI, Stalenhoef AF et al. Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther 2004;75:476483.
  • 29
    Takada K, Aksentijevich I, Mahadevan V, Dean JA, Kelley RI, Kastner DL. Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum 2003;48:26452651.
  • 30
    Marchetti F, Barbi E, Tommasini A, Oretti C, Ventura A. Inefficacy of etanercept in a child with hyper-IgD syndrome and periodic fever. Clin Exp Rheumatol 2004;22:791792.
  • 31
    Bodar EJ, Van Der Hilst JCH, Drenth JPH, Van Der Meer JWM, Simon A. Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Neth J Med 2005;63:260264.
  • 32
    Horwitz M, Benson KF, Person RE, Aprikyan AG, Dale DC. Neutrophil elastase mutations define a 21-day biological clock in cyclic hematopoiesis. Nat Gen 1999;23:433436.
  • 33
    Long SS. Distinguishing among prolonged, recurrent and periodic fever syndromes: approach of a pediatric infectious disease subspecialist. Pediatr Clin N Am 2005;52:811835.
  • 34
    Dale DC, Bolyard AA, Aprikyan A. Cyclic neutropenia. Semin Hematol 2002;39:8994.
  • 35
    Padeh S. Periodic fever syndromes. Pediatr Clin N Am 2005;52:577609.
  • 36
    Pras E, Aksentijevich I, Gruberg L, Balow JE Jr, Prosen L, Dean M et al. Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. N Engl J Med 1992;326:15091513.
  • 37
    Sohar E, Gafhi J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 1967;43:227253.
  • 38
    Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet 1998;351:659664.
  • 39
    Heller H, Gafni J, Michaeli D, Shahin N, Sohar E, Ehrlich G et al. The arthritis of familial Mediterranean fever (FMF). Arthritis Rheum 1966;9:117.
  • 40
    Bar-Eli M, Ehrenfeld M, Levy M, Gallily R, Eliakim M. Leukocyte chemotaxis in recurrent polyserositis (familial Mediterranean fever). Am J Med Sci 1981;281:1518.
  • 41
    Ozkaya N, Yalcinkaya F. Colchicine treatment in children with familial Mediterranean fever. Clin Rheumatol 2003;22:314317.
  • 42
    Hull KM, Drewe E, Aksentijevich I, Singh HK, Wong K, McDermott EM et al. The TNF receptor-associated periodic syndrome (TRAPS); emerging concepts of an autoinflammatory disorder. Medicine 2002;81:349368.
  • 43
    Aganna E, Hammond L, Hawkins PN, Aldea A, McKee SA, Van Amstel HKP et al. Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Arthritis Rheum 2003;48:26322644.
  • 44
    McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor (TNF-R1) define a family of dominantly inherited autoinflammatory syndromes. Cell 1999;97:133144.
  • 45
    Toro JR, Aksentijevich I, Hull K, Kastner DL. Tumor necrosis factor receptor-associated periodic fever syndrome: a novel syndrome with cutaneous manifestations. Arch Dermatol 2000;136:14871494.
  • 46
    Aksentijevich I, Galon J, Soares M, Mansfield E, Hull K, Oh HH et al. The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet 2001;69:301314.
  • 47
    Drewe E, Powell PT, Isaacs JD, Powell RJ. Prospective study of anti-tumor necrosis factor superfamily 1a and 1b fusion proteins in tumor necrosis factor receptor-associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of six patients. Rheumatology 2003;42:235239.
  • 48
    Hull KM, Singh HK, Aksentijevich I, O’Shea JJ, Kastner DL. Efficacy in the TNF receptor-associated periodic syndrome (TRAPS): results from an ongoing clinical trial. Arthritis Rheum 2001;44(Suppl. 9):SY11.
  • 49
    Derbes VJ, Coleman WP. Familial cold urticaria. Ann Allergy 1972;30:335341.
  • 50
    Porksen G, Lohse P, Rosen-Wolff A, Heyden S, Förster T, Wendisch J et al. Periodic fever, mild arthralgias, and reversible moderate and severe organ inflammation associated with the V198 M mutation in the CIAS1 gene in three German patients – expanding phenotype of CIAS1 related autoinflammatory syndrome. Eur J Haematol 2004;73:123127.
  • 51
    Muckle TJ, Wells M. Urticaria, deafness and amyloidosis: a new heredo-familial syndrome. QJM 1962;31:235.
  • 52
    Prieur AM. A recently recognized chronic inflammatory disease of early onset characterized by the triad of rash, central nervous system involvement and arthropathy. Clin Exp Rheumatol 2001;19:103106.
  • 53
    Goldbach-Mansky R, Dailey NJ, Canna SW, Gelabert A, Jones J, Rubin BI et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med 2006;355:581592.
  • 54
    Stack JH, Beaumont K, Larsen PD, Straley KS, Henkel GW, Randle JC et al. IL-converting enzyme/capsase-1 inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patients. J Immunol 2005;175:26302634.